ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 283,03
0,14%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aclarion Inc (ACON)

  7. Aclarion Inc (ACON) Actualités

ACON Aclarion Inc

0,2901
-0,0021 (-0,72%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Aclarion Inc ACON NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0021 -0,72% 0,2901 06:00:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,295 0,291 0,3094 0,2999 0,2922
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202415:14GLOBEAclarion’s Nociscan Solution to Play Key Role in..
06/3/202422:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/3/202414:00GLOBEAclarion Announces Publication of Compelling Peer-Reviewed..
27/2/202421:22GLOBEAclarion Announces Closing of $3.0 Million Public Offering
27/2/202420:00EDGAR2Form 8-K - Current report
27/2/202416:46EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
27/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/2/202415:15GLOBEAclarion Announces Pricing of $3.0 Million Public Offering
23/2/202417:46EDGAR2Form S-1/A - General form for registration of securities..
21/2/202423:25EDGAR2Form 8-K - Current report
21/2/202421:02EDGAR2Form S-1/A - General form for registration of securities..
06/2/202423:32EDGAR2Form S-1/A - General form for registration of securities..
05/2/202414:00GLOBEAclarion Announces Successful Financings; Plans to Launch..
01/2/202423:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/1/202423:26EDGAR2Form S-1/A - General form for registration of securities..
29/1/202412:04EDGAR2Form 8-K - Current report
23/1/202415:53EDGAR2Form 8-K - Current report
22/1/202422:48EDGAR2Form S-1 - General form for registration of securities under..
22/1/202414:00GLOBEAclarion Expands Nociscan Access Into Phoenix With Key..
17/1/202414:00GLOBEAclarion Announces Updated Product Release That Expands MRI..
12/1/202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202414:00GLOBEAclarion and ATEC Execute Strategic Partnership Agreement to..
04/1/202414:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/1/202414:00EDGAR2Form 8-K - Current report
02/1/202418:00GLOBEAclarion Announces Reverse Stock Split
29/12/202312:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/12/202322:30EDGAR2Form 8-K - Current report
11/12/202322:55EDGAR2Form S-1 - General form for registration of securities under..
27/11/202314:00GLOBEAclarion Announces Key Commercial Milestone With Completion..
22/11/202322:01EDGAR2Form 8-K - Current report
16/11/202322:58EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/11/202312:00EDGAR2Form DEF 14A - Other definitive proxy statements
08/11/202314:00GLOBEAclarion Announces Achievement of Goal to Enroll 10 Leading..
06/11/202314:00GLOBEAclarion Expands Immediate Nociscan Access Into New York..
01/11/202321:15EDGAR2Form PRE 14A - Other preliminary proxy statements
01/11/202313:00GLOBEAclarion Presents at the NIH HEAL Initiative Fall Meeting
30/10/202322:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
25/10/202314:30GLOBEAclarion Announces Signing of Commercial Agreement With..
24/10/202314:45GLOBEAclarion Announces Nociscan® Cost-Effectiveness Poster..
23/10/202314:55EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/10/202313:00GLOBEAclarion Announces Signing Strategic Partnership Letter of..
23/10/202312:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/10/202321:08EDGAR2Form S-1/A - General form for registration of securities..
10/10/202321:34EDGAR2Form S-1 - General form for registration of securities under..
10/10/202314:30EDGAR2Form 8-K - Current report
02/10/202314:00GLOBEAclarion Provides Updated Investor Presentation and..
28/9/202313:48EDGAR2Form 8-K - Current report
07/9/202322:01EDGAR2Form 8-K - Current report
31/8/202322:01EDGAR2Form 8-K - Current report
25/8/202322:42EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
ACON
Aclarion
BIT
P1Z794
NLBNPIT1Z794 20351221 37...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés